Ference, Brian A.

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., et al. (2018) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 200

Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development

Holmes, M. V., Richardson, T. G., Ference, B. A., Davies, N. M., & Davey Smith, G. (2021) · Nature Reviews Cardiology

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 184

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018) · European Heart Journal

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 161

How to use Mendelian randomization to anticipate the results of randomized trials

Ference, B. A. (2018) · European Heart Journal

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 96

Clinical Effect of Naturally Random Allocation to Lower Systolic Blood Pressure Beginning Before the Development of Hypertension

Ference, B. A., Julius, S., Mahajan, N., Levy, P. D., Williams, K. A., & Flack, J. M. (2014) · Hypertension

Blood Pressure and Hypertension StudiesGenetic Associations and Epidemiology

Cited by 77

Causal Effect of Lipids and Lipoproteins on Atherosclerosis

Ference, B. A. (2018) · Cardiology Clinics

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 28

Relationship of Resistant Hypertension and Treatment Outcomes With Total Arterial Compliance in a Predominantly African American Hypertensive Cohort

Bakhtar, O., Ference, B. A., Hedquist, L. A., Levy, P. D., & Flack, J. M. (2012) · The Journal of Clinical Hypertension

Cardiovascular Health and Disease PreventionBlood Pressure and Hypertension Studies

Cited by 14

Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options

Ference, B. A. (2019) · Clinical Pharmacology & Therapeutics

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 8